vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and SS Innovations International, Inc. (SSII). Click either name above to swap in a different company.

CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $14.5M, roughly 1.3× SS Innovations International, Inc.). SS Innovations International, Inc. runs the higher net margin — -17.0% vs -19.7%, a 2.7% gap on every dollar of revenue. On growth, SS Innovations International, Inc. posted the faster year-over-year revenue change (79.1% vs 35.8%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $-3.2M). Over the past eight quarters, SS Innovations International, Inc.'s revenue compounded faster (99.9% CAGR vs 26.5%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.

CURI vs SSII — Head-to-Head

Bigger by revenue
CURI
CURI
1.3× larger
CURI
$19.2M
$14.5M
SSII
Growing faster (revenue YoY)
SSII
SSII
+43.3% gap
SSII
79.1%
35.8%
CURI
Higher net margin
SSII
SSII
2.7% more per $
SSII
-17.0%
-19.7%
CURI
More free cash flow
CURI
CURI
$7.2M more FCF
CURI
$3.9M
$-3.2M
SSII
Faster 2-yr revenue CAGR
SSII
SSII
Annualised
SSII
99.9%
26.5%
CURI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CURI
CURI
SSII
SSII
Revenue
$19.2M
$14.5M
Net Profit
$-3.8M
$-2.5M
Gross Margin
43.9%
Operating Margin
-17.6%
-3.7%
Net Margin
-19.7%
-17.0%
Revenue YoY
35.8%
79.1%
Net Profit YoY
-34.6%
-28.5%
EPS (diluted)
$-0.07
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
SSII
SSII
Q4 25
$19.2M
$14.5M
Q3 25
$18.4M
$12.8M
Q2 25
$19.0M
$10.0M
Q1 25
$15.1M
$5.1M
Q4 24
$14.1M
$8.1M
Q3 24
$12.6M
$4.4M
Q2 24
$12.4M
$4.5M
Q1 24
$12.0M
$3.6M
Net Profit
CURI
CURI
SSII
SSII
Q4 25
$-3.8M
$-2.5M
Q3 25
$-3.7M
$-3.7M
Q2 25
$784.0K
$-256.7K
Q1 25
$319.0K
$-5.7M
Q4 24
$-2.8M
$-1.9M
Q3 24
$-3.1M
$-3.2M
Q2 24
$-2.0M
$-4.1M
Q1 24
$-5.0M
$-9.8M
Gross Margin
CURI
CURI
SSII
SSII
Q4 25
43.9%
Q3 25
48.1%
Q2 25
59.1%
Q1 25
21.2%
Q4 24
48.9%
Q3 24
52.8%
Q2 24
31.9%
Q1 24
20.0%
Operating Margin
CURI
CURI
SSII
SSII
Q4 25
-17.6%
-3.7%
Q3 25
-24.5%
-14.3%
Q2 25
2.5%
1.0%
Q1 25
0.5%
-115.6%
Q4 24
-27.4%
-22.7%
Q3 24
-25.8%
-73.1%
Q2 24
-20.6%
-90.9%
Q1 24
-30.4%
-270.3%
Net Margin
CURI
CURI
SSII
SSII
Q4 25
-19.7%
-17.0%
Q3 25
-20.4%
-29.0%
Q2 25
4.1%
-2.6%
Q1 25
2.1%
-111.0%
Q4 24
-19.9%
-23.7%
Q3 24
-24.3%
-74.0%
Q2 24
-16.4%
-91.8%
Q1 24
-42.0%
-270.5%
EPS (diluted)
CURI
CURI
SSII
SSII
Q4 25
$-0.07
$-0.01
Q3 25
$-0.06
$-0.02
Q2 25
$0.01
$0.00
Q1 25
$0.01
$-0.03
Q4 24
$-0.05
$-0.01
Q3 24
$-0.06
$-0.02
Q2 24
$-0.04
$-0.02
Q1 24
$-0.09
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
SSII
SSII
Cash + ST InvestmentsLiquidity on hand
$27.3M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$38.2M
Total Assets
$75.7M
$74.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
SSII
SSII
Q4 25
$27.3M
$3.2M
Q3 25
$27.8M
$5.7M
Q2 25
$28.1M
$11.4M
Q1 25
$33.4M
$15.9M
Q4 24
$32.1M
$466.5K
Q3 24
$33.2M
$220.4K
Q2 24
$39.5M
$608.2K
Q1 24
$38.8M
$948.1K
Stockholders' Equity
CURI
CURI
SSII
SSII
Q4 25
$41.5M
$38.2M
Q3 25
$47.2M
$39.6M
Q2 25
$49.8M
$42.0M
Q1 25
$58.1M
$40.6M
Q4 24
$57.8M
$13.5M
Q3 24
$62.2M
$13.7M
Q2 24
$64.8M
$14.8M
Q1 24
$67.0M
$16.7M
Total Assets
CURI
CURI
SSII
SSII
Q4 25
$75.7M
$74.2M
Q3 25
$74.7M
$69.6M
Q2 25
$78.7M
$70.0M
Q1 25
$85.3M
$63.5M
Q4 24
$86.2M
$42.4M
Q3 24
$87.6M
$39.0M
Q2 24
$90.9M
$35.7M
Q1 24
$94.6M
$35.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
SSII
SSII
Operating Cash FlowLast quarter
$4.0M
$-1.5M
Free Cash FlowOCF − Capex
$3.9M
$-3.2M
FCF MarginFCF / Revenue
20.5%
-22.3%
Capex IntensityCapex / Revenue
0.1%
11.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-22.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
SSII
SSII
Q4 25
$4.0M
$-1.5M
Q3 25
$4.4M
$-7.5M
Q2 25
$2.8M
$-3.5M
Q1 25
$1.9M
$-6.1M
Q4 24
$3.0M
$-3.3M
Q3 24
$2.3M
$-2.5M
Q2 24
$2.2M
$-1.0M
Q1 24
$666.0K
$-2.7M
Free Cash Flow
CURI
CURI
SSII
SSII
Q4 25
$3.9M
$-3.2M
Q3 25
$-8.2M
Q2 25
$-3.8M
Q1 25
$1.8M
$-7.0M
Q4 24
$-3.4M
Q3 24
$-4.2M
Q2 24
$-3.1M
Q1 24
$-2.8M
FCF Margin
CURI
CURI
SSII
SSII
Q4 25
20.5%
-22.3%
Q3 25
-64.1%
Q2 25
-37.7%
Q1 25
12.2%
-136.2%
Q4 24
-41.7%
Q3 24
-96.9%
Q2 24
-69.5%
Q1 24
-76.9%
Capex Intensity
CURI
CURI
SSII
SSII
Q4 25
0.1%
11.8%
Q3 25
0.0%
5.9%
Q2 25
0.0%
3.2%
Q1 25
0.5%
17.0%
Q4 24
0.0%
1.5%
Q3 24
0.0%
38.8%
Q2 24
0.0%
46.8%
Q1 24
0.0%
3.5%
Cash Conversion
CURI
CURI
SSII
SSII
Q4 25
Q3 25
Q2 25
3.56×
Q1 25
6.03×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CURI
CURI

Segment breakdown not available.

SSII
SSII

System Sales$13.4M92%
Other$1.2M8%

Related Comparisons